Cargando…
Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses
SARS-CoV-2 causes COVID-19, an acute respiratory distress syndrome (ARDS) characterized by pulmonary edema, viral pneumonia, multiorgan dysfunction, coagulopathy, and inflammation. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) receptors to infect and damage ciliated epithelial cells in the...
Autores principales: | Nascimento Conde, Jonas, Schutt, William R., Gorbunova, Elena E., Mackow, Erich R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751258/ https://www.ncbi.nlm.nih.gov/pubmed/33310781 http://dx.doi.org/10.1128/mBio.03185-20 |
Ejemplares similares
-
Blockade of Autocrine CCL5 Responses Inhibits Zika Virus Persistence and Spread in Human Brain Microvascular Endothelial Cells
por: Mladinich, Megan C., et al.
Publicado: (2021) -
ZIKV induction of tristetraprolin in endothelial and Sertoli cells post-transcriptionally inhibits IFNβ/λ expression and promotes ZIKV persistence
por: Schutt, William R., et al.
Publicado: (2023) -
Endothelial cell dysfunction in viral hemorrhage and edema
por: Mackow, Erich R., et al.
Publicado: (2015) -
Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication
por: Adams, Lily E., et al.
Publicado: (2021) -
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
por: Busnadiego, Idoia, et al.
Publicado: (2020)